Selection and characterization of naturally occurring single-domain (IgNAR) antibody fragments from immunized sharks by phage display
- PMID: 12909128
- DOI: 10.1016/s0161-5890(03)00084-1
Selection and characterization of naturally occurring single-domain (IgNAR) antibody fragments from immunized sharks by phage display
Abstract
The novel immunoglobulin isotype novel antigen receptor (IgNAR) is found in cartilaginous fish and is composed of a heavy-chain homodimer that does not associate with light chains. The variable regions of IgNAR function as independent domains similar to those found in the heavy-chain immunoglobulins of Camelids. Here, we describe the successful cloning and generation of a phage-displayed, single-domain library based upon the variable domain of IgNAR. Selection of such a library generated from nurse sharks (Ginglymostoma cirratum) immunized with the model antigen hen egg-white lysozyme (HEL) enabled the successful isolation of intact antigen-specific binders matured in vivo. The selected variable domains were shown to be functionally expressed in Escherichia coli, extremely stable, and bind to antigen specifically with an affinity in the nanomolar range. This approach can therefore be considered as an alternative route for the isolation of minimal antigen-binding fragments with favorable characteristics.
Similar articles
-
Rapid isolation of IgNAR variable single-domain antibody fragments from a shark synthetic library.Mol Immunol. 2007 Jan;44(4):656-65. doi: 10.1016/j.molimm.2006.01.010. Epub 2006 Feb 24. Mol Immunol. 2007. PMID: 16500706
-
The generation and selection of single-domain, v region libraries from nurse sharks.Methods Mol Biol. 2009;562:71-82. doi: 10.1007/978-1-60327-302-2_6. Methods Mol Biol. 2009. PMID: 19554288
-
Isolation and characterization of an IgNAR variable domain specific for the human mitochondrial translocase receptor Tom70.Eur J Biochem. 2003 Sep;270(17):3543-54. doi: 10.1046/j.1432-1033.2003.03737.x. Eur J Biochem. 2003. PMID: 12919318
-
Shark New Antigen Receptor (IgNAR): Structure, Characteristics and Potential Biomedical Applications.Cells. 2021 May 8;10(5):1140. doi: 10.3390/cells10051140. Cells. 2021. PMID: 34066890 Free PMC article. Review.
-
[Advances in the study of natural small molecular antibody].Yao Xue Xue Bao. 2012 Oct;47(10):1281-6. Yao Xue Xue Bao. 2012. PMID: 23289139 Review. Chinese.
Cited by
-
Construction of an artificially randomized IgNAR phage display library: screening of variable regions that bind to hen egg white lysozyme.Mar Biotechnol (NY). 2013 Feb;15(1):56-62. doi: 10.1007/s10126-012-9456-1. Epub 2012 May 3. Mar Biotechnol (NY). 2013. PMID: 22552958
-
Research and development of next generation of antibody-based therapeutics.Acta Pharmacol Sin. 2010 Sep;31(9):1198-207. doi: 10.1038/aps.2010.120. Epub 2010 Aug 9. Acta Pharmacol Sin. 2010. PMID: 20694021 Free PMC article. Review.
-
Shark IgNAR: The Next Broad Application Antibody in Clinical Diagnoses and Tumor Therapies?Mar Drugs. 2023 Sep 16;21(9):496. doi: 10.3390/md21090496. Mar Drugs. 2023. PMID: 37755109 Free PMC article. Review.
-
Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain.MAbs. 2012 Nov-Dec;4(6):673-85. doi: 10.4161/mabs.22242. MAbs. 2012. PMID: 23676205 Free PMC article.
-
Prokaryotic expression of antibodies and affibodies.Curr Opin Biotechnol. 2004 Aug;15(4):364-73. doi: 10.1016/j.copbio.2004.06.004. Curr Opin Biotechnol. 2004. PMID: 15296932 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources